![](/wp-content/uploads/2019/06/european-medicines-agency-announcement.png)
$599
Lilly Nasal Glucagon CHMP Opinion This Week (CHMP Agenda October 14-17)
The CHMP agenda for this week’s meeting (October 14-17) has been released, and it includes two notable items (Lilly nasal glucagon opinion and Toujeo age indication extension). Below, FENIX provides diabetes-related highlights and insights from the CHMP agenda.